IT8919730A0 - Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. - Google Patents

Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.

Info

Publication number
IT8919730A0
IT8919730A0 IT8919730A IT1973089A IT8919730A0 IT 8919730 A0 IT8919730 A0 IT 8919730A0 IT 8919730 A IT8919730 A IT 8919730A IT 1973089 A IT1973089 A IT 1973089A IT 8919730 A0 IT8919730 A0 IT 8919730A0
Authority
IT
Italy
Prior art keywords
bronchodilatator
activity
therapeutic applications
xanthine derivatives
xanthine
Prior art date
Application number
IT8919730A
Other languages
English (en)
Other versions
IT1229195B (it
Inventor
Stefano Poli
Lucio Del Corona
Germano Coppi
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT8919730A priority Critical patent/IT1229195B/it
Publication of IT8919730A0 publication Critical patent/IT8919730A0/it
Priority to DE199090104229T priority patent/DE386683T1/de
Priority to EP19900104229 priority patent/EP0386683A3/en
Priority to ES90104229T priority patent/ES2017899A4/es
Priority to JP2057835A priority patent/JPH03200787A/ja
Application granted granted Critical
Publication of IT1229195B publication Critical patent/IT1229195B/it
Priority to GR90300160T priority patent/GR900300160T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8919730A 1989-03-10 1989-03-10 Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. IT1229195B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8919730A IT1229195B (it) 1989-03-10 1989-03-10 Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
DE199090104229T DE386683T1 (de) 1989-03-10 1990-03-05 Xanthinderivate mit bronchodilatorischer aktivitaet, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP19900104229 EP0386683A3 (en) 1989-03-10 1990-03-05 Xanthine derivatives having bronchodilating activity, a process for the preparation thereof and pharmaceutical compositions containing them
ES90104229T ES2017899A4 (es) 1989-03-10 1990-03-05 Derivados xantino que tienen actividad broncodilatadora, un proceso para la preparacion de ello y compuestos farmaceuticos que los contienen
JP2057835A JPH03200787A (ja) 1989-03-10 1990-03-08 キサンチン誘導体、その製造法及びそれらを含む気管支拡張剤
GR90300160T GR900300160T1 (en) 1989-03-10 1991-09-27 Xanthine derivatives having bronchodilating activity, a process for the preparation thereof and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919730A IT1229195B (it) 1989-03-10 1989-03-10 Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.

Publications (2)

Publication Number Publication Date
IT8919730A0 true IT8919730A0 (it) 1989-03-10
IT1229195B IT1229195B (it) 1991-07-25

Family

ID=11160729

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8919730A IT1229195B (it) 1989-03-10 1989-03-10 Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.

Country Status (6)

Country Link
EP (1) EP0386683A3 (it)
JP (1) JPH03200787A (it)
DE (1) DE386683T1 (it)
ES (1) ES2017899A4 (it)
GR (1) GR900300160T1 (it)
IT (1) IT1229195B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
GB9210839D0 (en) * 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
JPH10508032A (ja) 1994-12-13 1998-08-04 ユーロ−セルティーク，エス．エイ． アリールチオキサンチン類
AU4527996A (en) 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
US6815446B1 (en) 1999-08-31 2004-11-09 Vanderbilt University Selective antagonists of A2B adenosine receptors
EP1251130B1 (en) 1999-12-24 2005-02-16 Kyowa Hakko Kogyo Co., Ltd. Fused purine derivatives
US20020012946A1 (en) 2000-02-23 2002-01-31 Luiz Belardinelli Method of identifying partial agonists of the A2A receptor
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
US7125993B2 (en) 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
PL370207A1 (en) 2001-11-09 2005-05-16 Cv Therapeutics, Inc. A2b adenosine receptor antagonists
US6977300B2 (en) 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
WO2003043637A1 (en) * 2001-11-20 2003-05-30 Bristol-Myers Squibb Pharma Company 3,7-dihydro-purine-2,6-dione derivatives as crf receptor ligands
US20050020915A1 (en) 2002-07-29 2005-01-27 Cv Therapeutics, Inc. Myocardial perfusion imaging methods and compositions
KR20050026546A (ko) 2002-07-29 2005-03-15 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ2ａ 수용체 작용제를 이용한 심근 관류 조영
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
WO2006044856A2 (en) 2004-10-20 2006-04-27 Cv Therapeuitics, Inc. Use of a2a adenosine receptor agonists
KR101494125B1 (ko) 2006-02-03 2015-02-16 길리애드 사이언시즈, 인코포레이티드 Ａ2ａ-아데노신 수용체 효능제 및 이의 다형체의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
US4338319A (en) * 1979-11-27 1982-07-06 Aktiebolaget Draco Method for the treatment of chronic obstructive airway or cardiac diseases
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
SE8602887D0 (sv) * 1986-06-27 1986-06-27 Draco Ab New chemical method

Also Published As

Publication number Publication date
GR900300160T1 (en) 1991-09-27
JPH03200787A (ja) 1991-09-02
IT1229195B (it) 1991-07-25
EP0386683A3 (en) 1992-01-15
DE386683T1 (de) 1991-02-07
EP0386683A2 (en) 1990-09-12
ES2017899A4 (es) 1991-03-16

Similar Documents

Publication Publication Date Title
IT8919730A0 (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
ITMI920528A0 (it) 14-beta idrossi-10-de acetil-baccatina iii, suoi derivati, loro preparazione ed impiego terapeutico
DE3582399D1 (de) Purin-derivate und ihre pharmazeutische verwendung.
IT1219940B (it) Benzo-b-pirani e piranopiridone,loro preparazione e loro impiego come medicamenti
DE69000467T2 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
DE58906076D1 (de) Benzophenonderivate und deren Herstellung.
NO905485D0 (no) Benzazepin- og benzotiazepin-derivater.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
IT1214648B (it) 8 alfa-acilamminoergoline,loro preparazione e loro impiego come medicamenti
DE3882099D1 (de) Hochempfindlicher elektromagnetischer ausloeser und dessen herstellung.
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
DE68906340D1 (de) Tetrahydronaphthalin und indan-derivate.
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
NO903229L (no) Substituerte isoksazol- og isotiazolderivater.
ITMI912422A0 (it) Derivati ossimici ad attivita' fungicida
DE69003056D1 (de) S-Alkylthiopropionsäuren und deren Derivate.
ITMI922071A0 (it) Derivati xantonici, loro preparazione ed attivita'
TR24169A (tr) Benzohidroksamik tuerevleri, bunlarin herbisitler olarak kullanilmasi vebunlari
IT8919402A0 (it) Pirimidine 2 4 disostituite loro preparazione ed impieghi terapeutici.
IT1227892B (it) Composizioni farmaceutiche ad attivita' antidepressiva e ansiolitica
IT1232692B (it) Derivati ergolinici con attivita' dopaminergica